Impact Publications : AirCargo-249
AIRCARGO ASIA-PACIFIC • JUNE-JULY 2017 • Page 17 those expectations. However the description of the approach which the DIBP will adopt, taking into account its assessment of the actions of parties could be seen as implicitly making a value judgment on the behaviour of all parties! A quick fix? Let’s blame the financiers? It occurs to me that the term ‘Owner’ is so broad that it could be applied to parties who finance the import transaction, whether they are banks or other financial institutions, who make a profit from the underlying commercial deal and who may well claim an interest in the relevant goods. Those financing parties seem to be successful in their commercial endeavours so perhaps the DIBP may consider them as the default party against whom recovery should be sought? That inclination may well increase as financial institutions continue to dictate the terms of commercial deals and how they are documented, such as in the Blockchain environment. Surely that level of control could translate into an obligation to ensure that the commercial deal is done properly including the payment of the correct customs duty? They may seem more worthy of being pursued for the Customs duty than the licensed Customs broker or freight for- warder who merely facilitate the logistics! What to do? You need to understand the potential liability and take steps to mitigate the risk. That includes a suite of responses such as tighter terms and conditions of trade, insurance and better work practic- es. We will be dealing with some of these in a CBFCA webinar next week. Of course – as always, if pain persists, please consult your lawyer. Qatar adds two cities to its pharma network QATAR Airways Cargo has added Colombo, Sri Lanka and Dub- lin, Ireland to its extensive Pharma network, bringing the cargo carrier’s pharmaceutical transport network to 73 destinations globally. Colombo was added on 15 May and Dublin started on 12 June 2017, when Qatar Airways commenced its B787 flights to the Irish capital. The Republic of Ireland has become one of the leading global hubs for the pharmaceutical industry, with nine of the top 10 largest phar- maceutical companies operating in the country. Sri Lanka, an importer of pharmaceuticals and healthcare products, expects future earnings from pharmaceutical exports to surpass tea export revenue. A pharmaceutical manufacturing project launched at the country’s Export Pro- cessing Zone last year. Qatar Airways’ chief of- ficer Cargo Ulrich Ogier- mann said: “We are experi- encing consistent growth each year in the air freight of pharmaceuticals and healthcare products glob- ally. The expansion of our pharma network to these destinations gives us the opportunity to support expanding pharma businesses in Sri Lanka, the Republic of Ireland and globally. “Customers stand to benefit from a seamless cool chain as well as uncompromising service standards. Qatar Airways Cargo customers in the Republic of Ireland will also greatly benefit in terms of time and cost savings, as they will no longer have to truck their freight from the Republic of Ireland to the United Kingdom.” The addition of Colombo and Dublin to the pharma network will enable Qatar Airways Cargo to offer its specialist pharmaceuticals transport solution, ‘QR Pharma’ to an expanding global customer base. QR Pharma is the cargo airline’s specialist product developed for phar- maceuticals and healthcare cargo. It offers active solutions to maintain a consistent temperature throughout the transportation chain, as well as passive solutions, which keep the pharmaceuticals within a defined temperature band during all stages of the journey. As an industry leader, the cargo carrier ensures the fastest transfer at Doha through its unique Quick Ramp Transfer (QRT). Qatar Airways Cargo is the only cargo carrier in the Middle East to offer refrigerated or ‘reefer’ truck services for ramp transfers at its home hub. Qatar Airways Cargo has invested considerably in quality handling, infrastructure, facilities, people and procedures at each of its pharma stations, as well as implementing a complete quality audit and stringent training modules, ensuring high operating standards for phar- maceuticals and healthcare products. Expertly-trained staff are on hand at every pharma destination to ensure the cool chain is unbroken.